Clinical characteristics and risk factors of intestinal involvement in Behçet’s syndrome patients: a cross-sectional study from a single center
Tóm tắt
Intestinal Behçet’s syndrome (BS) has high morbidity and mortality rates with serious complications. The purpose of this study was to investigate the clinical characteristics and laboratory parameters of intestinal and mucocutaneous BS patients and analyze the risk factors of intestinal involvement in BS patients. A retrospective analysis was used to collect the demographic data and laboratory parameters from 97 intestinal and 154 mucocutaneous BS patients. Univariate and multivariate logistic regression analyses were used to investigate the risk factors of intestinal involvement in BS patients. The most common clinical manifestations of first onset in intestinal BS patients were oral ulceration (100.00%), followed by genital ulcers (62.89%) and erythema nodule (28.87%), gastrointestinal lesions (28.87%), pseudofolliculitis (25.77%), fever (17.53%), arthritis (16.49%), ocular involvement (5.15%), while the least common were vascular involvement (2.06%) and hematologic involvement involvement (2.06%). The most common intestinal segment involved in intestinal BS patients was terminal ileum (30.9%), followed by ileocecal (18.6%), colon (15.5%). By univariate logistic regression analysis, gender, age at hospitalization, age of disease onset, BDCAF, T-SPOT, fever, erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), leukocyte, erythrocyte, hemoglobin (HGB), neutrophil-to-lymphocyte ratio, serum amyloid A, complement 3, albumin, total cholesterol, high-density lipoprotein and interleukin 6 (IL-6) were found all risk factors of intestinal involvement in BS patients (P < 0.05 or P = 0.00). Moreover, gender (male), BDCAF (≥ 2), ESR (≥ 15 mm/H), CRP (> 10 mg/L), HGB (< 130 g/L) and IL-6 (> 7 pg/ml) were found the independent risk factors of intestinal involvement in BS patients (all P < 0.05). More attention shall be paid to gender, BDCAF, ESR, CRP, HGB and IL-6 in BS patients. When gender (male), BDCAF (≥ 2), ESR (≥ 15 mm/H), CRP (> 10 mg/L), HGB (< 130 g/L) and IL-6 (> 7 pg/ml) being observed, it may reminds that the presence of intestinal involvement in BS patients.
Tài liệu tham khảo
Hatemi I, Hatemi G, Celik AF. Gastrointestinal involvement in Behcet disease. Rheum Dis Clin North Am. 2018;44:45–64.
Leccese P, Alpsoy E. Behcet’s disease: an overview of etiopathogenesis. Front Immunol. 2019;10:1067.
Yazici H, Seyahi E, Hatemi G, Yazici Y. Behcet syndrome: a contemporary view. Nat Rev Rheumatol. 2018;14:107–19.
Cheon JH, Kim ES, Shin SJ, Kim TI, Lee KM, et al. Development and validation of novel diagnostic criteria for intestinal Behçet’s disease in Korean patients with ileocolonic ulcers. Am J Gastroenterol. 2009;104:2492–9.
Zhang Z, He F, Shi Y. Behcet’s disease seen in China: analysis of 334 cases. Rheumatol Int. 2013;33:645–8.
Ye JF, Guan JL. Differentiation between intestinal Behcet’s disease and Crohn’sdisease based on endoscopy. Turk J Med Sci. 2019;49:42–9.
Smith JA, Siddiqui D. Intestinal Behçet’s disease presenting as a massive acute lower gastrointestinal bleed. Dig Dis Sci. 2002;47:517–21.
Jung YS, Yoon JY, Lee JH, Jeon SM, Hong SP, et al. Prognostic factors and long-term clinical outcomes for surgical patients with intestinal Behcet’s disease. Inflamm Bowel Dis. 2011;17:1594–602.
Senusi AA, Liu J, Bevec D, Bergmeier LA, Stanford M, et al. Why are Behçet’s disease patients always exhausted? Clin Exp Rheumatol. 2018;36:53–62.
Talaat RM, Sibaii H, Bassyouni IH, El-Wakkad A. IL-17, IL-10, IL-6, and IFN-γ in Egyptian Behçet’s disease: correlation with clinical manifestations. Eur Cytokine Netw. 2019;30:15–22.
Talaat RM, Ashour ME, Bassyouni IH, Raouf AA. Polymorphisms of interleukin 6 and interleukin 10 in Egyptian people with Behcet’s disease. Immunobiology. 2014;219:573–82.
Hatemi G, Esatoglu SN, Yazici Y. Biomarkers in vasculitis. Curr Opin Rheumatol. 2018;30:30–5.
The International Criteria for Behcet's Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria. J Eur Acad Dermatol Venereol JEADV. 2014;28:338–47.
Lawton G, Bhakta BB, Chamberlain MA, Tennant A. The Behcet’s disease activity index. Rheumatology (Oxford). 2004;43:73–8.
Park YE, Cheon JH, Park Y, Park SJ, Kim TI, Kim WH. The outcomes and risk factors of early readmission in patients with intestinal Behcet’s disease. Clin Rheumatol. 2018;37:1913–20.
Zhang L, Tian Y, Ye JF, Lin CH, Guan JL. Poor prognostic factors in patients with newly diagnosed intestinal Adamantiades-Behçet’s disease in the Shanghai Adamantiades-Behçet’s disease database: a prospective cohort study. Orphanet J Rare Dis. 2019;14:274.
Han M, Jung YS, Kim WH, Cheon JH, Park S. Incidence and clinical outcomes of intestinal Behcet’s disease in Korea, 2011–2014: a nationwide population-based study. J Gastroenterol. 2017;52:920–8.
Bayraktar Y, Ozaslan E, Van Thiel DH. Gastrointestinal manifestations of Behcet’s disease. J Clin Gastroenterol. 2000;30:144–54.
Talarico R, Elefante E, Parma A, Taponeco F, Simoncini T, Mosca M. Sexual dysfunction in Behcet’s syndrome. Rheumatol Int. 2020;40:9–15.
Ishido T, Horita N, Takeuchi M, Kawagoe T, Shibuya E, et al. Clinical manifestations of Behçet’s disease depending on sex and age: results from Japanese nationwide registration. Rheumatology (Oxford). 2017;56:1918–27.
Hamzaoui A, Jaziri F, Ben Salem T, Said Imed Ben Ghorbel F, Lamloum M, et al. Comparison of clinical features of Behcet disease according to age in a Tunisian cohort. Acta Med Iranica. 2014;52:748–51.
Yazici H, Tüzün Y, Pazarli H, Yurdakul S, Ozyazgan Y, et al. Influence of age of onset and patient’s sex on the prevalence and severity of manifestations of Behçet’s syndrome. Ann Rheum Dis. 1984;43:783–9.
Zhang T, Hong L, Wang Z, Fan R, Zhang M, et al. Comparison between Intestinal Behçet’s disease and Crohn’s disease in characteristics of symptom, endoscopy, and radiology. Gastroenterol Res Pract 2017:3918746.
Shen Y, Ma HF, Luo D, Cai JF, Zou J, Guan JL. High incidence of gastrointestinal ulceration and cytogenetic aberration of trisomy 8 as typical features of Behçet’s disease associated with Myelodysplastic syndrome: a series of 16 consecutive Chinese patients from the Shanghai Behçet’s disease database and comparison with the literature. Biomed Res Int. 2018;2018:8535091.
Zou J, Shen Y, Ji DN, Zheng SB, Guan JL. Endoscopic findings of gastrointestinal involvement in Chinese patients with Behcet’s disease. World J Gastroenterol. 2014;20:17171–8.
Lee YH, Song GG. Neutrophil-to-lymphocyte ratio, mean platelet volume and platelet-to-lymphocyte ratio in Behcet’s disease and their correlation with disease activity: a meta-analysis. Int J Rheum Dis. 2018;21:2180–7.
Park J, Cheon JH, Park Y, Park SJ, Kim TI, Kim WH. Risk factors and outcomes of emergency room visits in intestinal Behçet’s disease. Digestion. 2017;96(4):231–8.
Lee HJ, Kim JH, Kim SW, Joo HA, Lee HW, et al. Proteomic analysis of serum amyloid a as a potential marker in intestinal Behçet’s disease. Dig Dis Sci. 2017;62:1953–62.
Chambers RE, Stross P, Barry RE, Whicher JT. Serum amyloid A protein compared with C-reactive protein, alpha 1-antichymotrypsin and alpha 1-acid glycoprotein as a monitor of inflammatory bowel disease. Eur J Clin Invest. 1987;17:460–7.
Hatemi I, Esatoglu SN, Hatemi G, Erzin Y, Yazici H, Celik AF. Characteristics, treatment, and long-term outcome of gastrointestinal involvement in Behcet’s syndrome: a strobe-compliant observational study from a dedicated multidisciplinary center. Medicine. 2016;95:e3348.
Lee JH, Cheon JH, Hong SP, Kim TI, Kim WH. Seasonal variation in flares of intestinal Behçet’s disease. Dig Dis Sci. 2015;60:3373–8.
Choi IJ, Kim JS, Cha SD, Jung HC, Park JG, et al. Long-term clinical course and prognostic factors in intestinal Behçet’s disease. Dis Colon Rectum. 2000;43:692–700.
Lee CR, Kim WH, Cho YS, Kim MH, Kim JH, et al. Colonoscopic findings in intestinal Behçet’s disease. Inflamm Bowel Dis. 2001;7:243–9.
Kim JS, Lim SH, Choi IJ, Moon H, Jung HC, et al. Prediction of the clinical course of Behçet’s colitis according to macroscopic classification by colonoscopy. Endoscopy. 2000;32:635–40.
Jung YS, Yoon JY, Hong SP, Kim TI, Kim WH, Cheon JH. Influence of age at diagnosis and sex on clinical course and long-term prognosis of intestinal Behcet’s disease. Inflamm Bowel Dis. 2012;18(6):1064–71.
Ye JF, Chen Y, Cai JF, Shen Y, Zou J, Guan JL. Incidence and risk factors for anemia among newly-diagnosed intestinal Behcet’s disease patients. J Natl Med Assoc. 2019;111:407–12.
Watanabe K, Tanida S, Inoue N, Kunisaki R, Kobayashi K, Nagahori M, et al. Evidence-based diagnosis and clinical practice guidelines for intestinal Behçet’s disease 2020 edited by Intractable Diseases, the Health and Labour Sciences Research Grants. J Gastroenterol. 2020;55(7):679–700.
Zou J, Luo JF, Shen Y, Cai JF, Guan JL. Cluster analysis of phenotypes of patients with Behcet’s syndrome: a large cohort study from a referral center in China. Arthritis Res Ther. 2021;23(1):45.